These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6818337)

  • 1. Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.
    Okada H; Yamazaki I; Ogawa Y; Hirai S; Yashiki T; Mima H
    J Pharm Sci; 1982 Dec; 71(12):1367-71. PubMed ID: 6818337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats II: mechanism of absorption enhancement with organic acids.
    Okada H; Yamazaki I; Yashiki T; Mima H
    J Pharm Sci; 1983 Jan; 72(1):75-8. PubMed ID: 6402584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay.
    Okada H; Yamazaki I; Yashiki T; Shimamoto T; Mima H
    J Pharm Sci; 1984 Mar; 73(3):298-302. PubMed ID: 6425491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats III: Effect of estrous cycle on vaginal absorption of hydrophilic model compounds.
    Okada H; Yashiki T; Mima H
    J Pharm Sci; 1983 Feb; 72(2):173-6. PubMed ID: 6403693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of gonadotropin-releasing response following vaginal consecutive administration of leuprolide in rats.
    Okada H; Yamazaki I; Sakura Y; Yashiki T; Shimamoto T; Mima H
    J Pharmacobiodyn; 1983 Jul; 6(7):512-22. PubMed ID: 6417315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
    Okada H; Sakura Y; Kawaji H; Yashiki T; Mima H
    Cancer Res; 1983 Apr; 43(4):1869-74. PubMed ID: 6403230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration patterns of an LHRH agonist, gonadotrophins and sex steroids after subcutaneous, vaginal, rectal and nasal administration of the agonist to pregnant rats.
    Yamazaki I
    J Reprod Fertil; 1984 Sep; 72(1):129-36. PubMed ID: 6433008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the pregnancy-terminating effectiveness of an LH-RH analogue by subcutaneous, vaginal, rectal, and nasal routes in rats.
    Yamazaki I
    Endocrinol Jpn; 1982 Aug; 29(4):415-21. PubMed ID: 6818022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of ovulation in the rat by an orally active antagonist of luteinizing hormone-releasing hormone.
    Nekola MB; Horvath A; Ge LJ; Coy DH; Schally AV
    Science; 1982 Oct; 218(4568):160-2. PubMed ID: 6750790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
    Adjei A; Sundberg D; Miller J; Chun A
    Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of formulation adjuvants on gastrointestinal absorption of leuprolide acetate.
    Adjei A; Love S; Johnson E; Diaz G; Greer J; Haviv F; Bush E
    J Drug Target; 1993; 1(3):251-8. PubMed ID: 8069567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
    Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary delivery of peptide drugs: effect of particle size on bioavailability of leuprolide acetate in healthy male volunteers.
    Adjei A; Garren J
    Pharm Res; 1990 Jun; 7(6):565-9. PubMed ID: 2114618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis.
    Sakata M; Terakawa N; Mizutani T; Tanizawa O; Matsumoto K; Terada N; Sudo K
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1679-84. PubMed ID: 2122726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics.
    Haviy F; Fitzpatrick TD; Nichols CJ; Swenson RE; Bush EN; Diaz G; Nguyen A; Nellans HN; Hoffman DJ; Ghanbari H
    J Med Chem; 1992 Oct; 35(21):3890-4. PubMed ID: 1433199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation induced by a gonadotropin releasing hormone analog in hypophysectomized rats involves prostaglandins.
    Ekholm C; Clark MR; Magnusson C; Isaksson O; LeMaire WJ
    Endocrinology; 1982 Jan; 110(1):288-90. PubMed ID: 7032895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone-releasing hormone, ovariectomy, and silastic vaginal rings in the Rhesus monkey.
    Kragt CL; Gala RR
    Fertil Steril; 1977 Aug; 28(8):856-62. PubMed ID: 407108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotropin releasing hormone analogue in the rat.
    English HF; Santner SJ; Levine HB; Santen RJ
    Cancer Res; 1986 Jan; 46(1):38-42. PubMed ID: 3079588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.
    Okada H; Inoue Y; Heya T; Ueno H; Ogawa Y; Toguchi H
    Pharm Res; 1991 Jun; 8(6):787-91. PubMed ID: 1905810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.